1. Chen, Shengnan, Li, Bo, Chen, Lei, Jiang, Hongli. 2023. Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation. In Journal of translational medicine, 21, 380. doi:10.1186/s12967-023-04233-0. https://pubmed.ncbi.nlm.nih.gov/37308949/
2. Li, Qingqing, Wang, Rui, Yang, Zhenlin, Tang, Fuchou, Wang, Jie. 2022. Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq. In Genome medicine, 14, 87. doi:10.1186/s13073-022-01089-9. https://pubmed.ncbi.nlm.nih.gov/35962452/
3. Di Benedetto, Carolina, Borini Etichetti, Carla, Cocordano, Nabila, Rosano, Germán Leandro, Girardini, Javier. 2023. The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer. In Frontiers in molecular biosciences, 10, 1145279. doi:10.3389/fmolb.2023.1145279. https://pubmed.ncbi.nlm.nih.gov/37780210/
4. El-Far, Mohamed, Abdelrazek, Mohamed A, Foda, Basma M, Abouzid, Amr, Swellam, Menha. 2024. Potential Role of AKR1B1 Gene Methylation in Diagnosis of Patients With Breast Cancer. In Clinical Medicine Insights. Oncology, 18, 11795549241290796. doi:10.1177/11795549241290796. https://pubmed.ncbi.nlm.nih.gov/39445312/
5. Ji, Jie, Xu, Min-Xue, Qian, Tian-Yang, Zhou, Juan, Xiao, Ming-Bing. 2020. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer. In Molecular biology reports, 47, 6091-6103. doi:10.1007/s11033-020-05685-z. https://pubmed.ncbi.nlm.nih.gov/32761301/
智鼠故事 
